Literature DB >> 25022196

Tyrosine phosphorylation in Toll-like receptor signaling.

Saurabh Chattopadhyay1, Ganes C Sen2.   

Abstract

There is a wealth of knowledge about how different Ser/Thr protein kinases participate in Toll-like receptor (TLR) signaling. In many cases, we know the identities of the Ser/Thr residues of various components of the TLR-signaling pathways that are phosphorylated, the functional consequences of the phosphorylation and the responsible protein kinases. In contrast, the analysis of Tyr-phosphorylation of TLRs and their signaling proteins is currently incomplete, because several existing analyses are not systematic or they do not rely on robust experimental data. Nevertheless, it is clear that many TLRs require, for signaling, ligand-dependent phosphorylation of specific Tyr residues in their cytoplasmic domains; the list includes TLR2, TLR3, TLR4, TLR5, TLR8 and TLR9. In this article, we discuss the current status of knowledge of the effect of Tyr-phosphorylation of TLRs and their signaling proteins on their biochemical and biological functions, the possible identities of the relevant protein tyrosine kinases (PTKs) and the nature of regulations of PTK-mediated activation of TLR signaling pathways.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EGFR; Protein tyrosine kinases; Src; TLR; Tyrosine phosphorylation

Mesh:

Substances:

Year:  2014        PMID: 25022196      PMCID: PMC4254339          DOI: 10.1016/j.cytogfr.2014.06.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  90 in total

1.  The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway.

Authors:  Pengyuan Yang; Huazhang An; Xingguang Liu; Mingyue Wen; Yuanyuan Zheng; Yaocheng Rui; Xuetao Cao
Journal:  Nat Immunol       Date:  2010-05-09       Impact factor: 25.606

2.  Lyn kinase controls TLR4-dependent IKK and MAPK activation modulating the activity of TRAF-6/TAK-1 protein complex in mast cells.

Authors:  Martin Avila; Adriana Martinez-Juarez; Alfredo Ibarra-Sanchez; Claudia Gonzalez-Espinosa
Journal:  Innate Immun       Date:  2012-02-02       Impact factor: 2.680

Review 3.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.

Authors:  Luke A J O'Neill; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 4.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.

Authors:  Tuanzhu Ha; Yulong Hu; Li Liu; Chen Lu; Julie R McMullen; Jim Kelley; Race L Kao; David L Williams; Xiang Gao; Chuanfu Li
Journal:  Cardiovasc Res       Date:  2010-04-26       Impact factor: 10.787

6.  Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha.

Authors:  Alessio Paone; Roberta Galli; Chiara Gabellini; Dmitriy Lukashev; Donatella Starace; Agnes Gorlach; Paola De Cesaris; Elio Ziparo; Donatella Del Bufalo; Michail V Sitkovsky; Antonio Filippini; Anna Riccioli
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

7.  Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b.

Authors:  Chaofeng Han; Jing Jin; Sheng Xu; Haibo Liu; Nan Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2010-07-18       Impact factor: 25.606

8.  Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.

Authors:  Andrei E Medvedev; Wenji Piao; Joanna Shoenfelt; Sang Hoon Rhee; Haiyan Chen; Subhendu Basu; Larry M Wahl; Matthew J Fenton; Stefanie N Vogel
Journal:  J Biol Chem       Date:  2007-03-28       Impact factor: 5.157

Review 9.  Triggering the innate antiviral response through IRF-3 activation.

Authors:  John Hiscott
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

10.  TLR3 deficiency in patients with herpes simplex encephalitis.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Sophie Ugolini; Asma Smahi; Gaëlle Elain; Pedro Romero; David Segal; Vanessa Sancho-Shimizu; Lazaro Lorenzo; Anne Puel; Capucine Picard; Ariane Chapgier; Sabine Plancoulaine; Matthias Titeux; Céline Cognet; Horst von Bernuth; Cheng-Lung Ku; Armanda Casrouge; Xin-Xin Zhang; Luis Barreiro; Joshua Leonard; Claire Hamilton; Pierre Lebon; Bénédicte Héron; Louis Vallée; Lluis Quintana-Murci; Alain Hovnanian; Flore Rozenberg; Eric Vivier; Frédéric Geissmann; Marc Tardieu; Laurent Abel; Jean-Laurent Casanova
Journal:  Science       Date:  2007-09-14       Impact factor: 47.728

View more
  43 in total

1.  Toll-like receptor 3 acts as a suppressor gene in breast cancer initiation and progression: a two-stage association study and functional investigation.

Authors:  Lei Fan; Peng Zhou; Qi Hong; Ao-Xiang Chen; Guang-Yu Liu; Ke-Da Yu; Zhi-Ming Shao
Journal:  Oncoimmunology       Date:  2019-03-30       Impact factor: 8.110

Review 2.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

3.  The R753Q polymorphism in Toll-like receptor 2 (TLR2) attenuates innate immune responses to mycobacteria and impairs MyD88 adapter recruitment to TLR2.

Authors:  Goutham Pattabiraman; Rahul Panchal; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2017-04-25       Impact factor: 5.157

4.  Constitutively Bound EGFR-Mediated Tyrosine Phosphorylation of TLR9 Is Required for Its Ability To Signal.

Authors:  Manoj Veleeparambil; Darshana Poddar; Samar Abdulkhalek; Patricia M Kessler; Michifumi Yamashita; Saurabh Chattopadhyay; Ganes C Sen
Journal:  J Immunol       Date:  2018-03-12       Impact factor: 5.422

5.  TLR8 Couples SOCS-1 and Restrains TLR7-Mediated Antiviral Immunity, Exacerbating West Nile Virus Infection in Mice.

Authors:  Amber M Paul; Dhiraj Acharya; Linda Le; Penghua Wang; Dobrivoje S Stokic; A Arturo Leis; Lena Alexopoulou; Terrence Town; Richard A Flavell; Erol Fikrig; Fengwei Bai
Journal:  J Immunol       Date:  2016-10-21       Impact factor: 5.422

Review 6.  GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance.

Authors:  Laure Aurelian; Irina Balan
Journal:  Psychopharmacology (Berl)       Date:  2019-04-27       Impact factor: 4.530

7.  Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Babak Baban; Jennifer C Sullivan; Takayuki Matsumoto; R Clinton Webb
Journal:  Cardiovasc Res       Date:  2015-04-24       Impact factor: 10.787

8.  The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.

Authors:  Romina Fiorotto; Ambra Villani; Antonis Kourtidis; Roberto Scirpo; Mariangela Amenduni; Peter J Geibel; Massimiliano Cadamuro; Carlo Spirli; Panos Z Anastasiadis; Mario Strazzabosco
Journal:  Hepatology       Date:  2016-10-27       Impact factor: 17.425

9.  EGFR-mediated tyrosine phosphorylation of STING determines its trafficking route and cellular innate immunity functions.

Authors:  Chenyao Wang; Xin Wang; Manoj Veleeparambil; Patricia M Kessler; Belinda Willard; Saurabh Chattopadhyay; Ganes C Sen
Journal:  EMBO J       Date:  2020-09-14       Impact factor: 11.598

10.  EGFR kinase activity is required for TLR4 signaling and the septic shock response.

Authors:  Saurabh Chattopadhyay; Manoj Veleeparambil; Darshana Poddar; Samar Abdulkhalek; Sudip K Bandyopadhyay; Volker Fensterl; Ganes C Sen
Journal:  EMBO Rep       Date:  2015-09-04       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.